Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Sueishi K, Kaneda Y, Sugimachi K
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Vasc Surg. 1998 Jan;27(1):135-44. doi: 10.1016/s0741-5214(98)70300-3.
Late graft failure is a critical problem, particularly in the presence of poor runoff vessels. Intimal hyperplasia is considered to be the main cause of graft failure. We have already reported that intimal thickening of experimental vein grafts in dogs with poor runoff vessels is more pronounced than that in dogs with normal vessels. We and others also have reported that production of nitric oxide (NO) in the endothelium of canine vein grafts is impaired. In the present study, we asked whether in vivo gene transfer of endothelial cell NO synthase (ecNOS) would inhibit intimal hyperplasia of autogenous vein grafts implanted in limbs with poor distal runoff in dogs.
After exposing femoral veins, the nuclear-targeted lac Zgene, bovine ecNOS cDNA, or control vector plasmid encapsulated in the hemagglutinating virus of Japan-liposomes was infused intraluminally, followed by incubation for 10 minutes at room temperature under a distending pressure of 100 mm Hg. Twenty reversed vein grafts were implanted under normal runoff conditions, and 4 days later these were used to confirm gene transfer to the vein grafts. Twelve reversed vein grafts were implanted under conditions of poor runoff, and 4 weeks after the operation intimal thickening was evident.
In vein grafts under normal runoff conditions, lac Z gene transfer exhibited diffuse and frequent X-Gal-positive signals in both medial and adventitial layers 4 days after implantation (n = 3). In case of the ecNOS gene-transferred vein grafts, bovine ecNOS protein was mainly detected in medial smooth muscle cells and adventitial cells 4 days after implantation, determined using immunohistochemical techniques and bovine ecNOS specific antibody (n = 3). In addition, ecNOS-transferred vessels showed intense purple signals by reduced nicotinamide adenine dinucleotide phosphate diaphorase and nitroblue tetrazolium reaction, in both medial and adventitial layers, whereas weak NOS activity was recognized at the adventitial vasa vasorum of the untreated veins or control vector transferred veins (n = 3, respectively). In vein grafts under poor runoff conditions, the intimal thickness at 4 weeks after implantation was significantly reduced by ecNOS gene transfer (n = 4; 90.0 +/- 7.6 microns and 1.18 +/- 0.07 mm2) in comparison with buffer-treated vessels (n = 4; 195.8 +/- 25.7 microns and 2.62 +/- 0.48 mm2) or vector vehicle-treated vessels (n = 4; 193.0 +/- 15.8 microns and 2.65 +/- 0.22 mm2).
Our findings show that gene transfer of ecNOS inhibited intimal hyperplasia of canine vein grafts caused by poor runoff conditions, as a result of an increased local production of NO. Thus ecNOS gene transfer warrants further study as a possible approach to prevent late graft failure.
晚期移植物失败是一个关键问题,尤其是在存在不良流出血管的情况下。内膜增生被认为是移植物失败的主要原因。我们已经报道,在流出血管不良的犬实验性静脉移植物中,内膜增厚比血管正常的犬更为明显。我们和其他人还报道,犬静脉移植物内皮细胞一氧化氮(NO)的产生受损。在本研究中,我们探讨了内皮细胞一氧化氮合酶(ecNOS)的体内基因转移是否会抑制植入犬远端流出不良肢体的自体静脉移植物的内膜增生。
暴露股静脉后,将包裹在日本血凝病毒脂质体中的核靶向lac Z基因、牛ecNOS cDNA或对照载体质粒腔内注入,然后在室温下100 mmHg的扩张压力下孵育10分钟。20个反转静脉移植物在正常流出条件下植入,4天后用于确认基因转移至静脉移植物。12个反转静脉移植物在流出不良的条件下植入,术后4周内膜增厚明显。
在正常流出条件下的静脉移植物中,植入后4天,lac Z基因转移在内膜和外膜层均显示弥漫且频繁的X-Gal阳性信号(n = 3)。在ecNOS基因转移的静脉移植物中,植入后4天,使用免疫组织化学技术和牛ecNOS特异性抗体测定,牛ecNOS蛋白主要在内膜平滑肌细胞和外膜细胞中检测到(n = 3)。此外,ecNOS转移的血管在内膜和外膜层通过还原型烟酰胺腺嘌呤二核苷酸磷酸黄递酶和硝基蓝四唑反应显示强烈的紫色信号,而在未处理静脉或对照载体转移静脉的外膜血管中仅识别到微弱的NOS活性(分别为n = 3)。在流出不良条件下的静脉移植物中,与缓冲液处理的血管(n = 4;195.8 +/- 25.7微米和2.62 +/- 0.48平方毫米)或载体处理的血管(n = 4;193.0 +/- 15.8微米和2.65 +/- 0.22平方毫米)相比,ecNOS基因转移在植入后4周时内膜厚度显著降低(n = 4;90.0 +/- 7.6微米和1.18 +/- 0.07平方毫米)。
我们的研究结果表明,ecNOS基因转移抑制了由流出不良条件引起的犬静脉移植物内膜增生,这是由于局部NO产生增加所致。因此,ecNOS基因转移作为预防晚期移植物失败的一种可能方法值得进一步研究。